Latest News From RBM

After a two-year period of broad consultation and discussion, the RBM Board decided to establish a new, more robust structure that takes advantage of the tremendous skill, energy and effectiveness of its many partners and to move conclusively into a new era that will take action to realize the vision of a world free of malaria.

As part of this new structure, RBM Board decided to launch a process for the establishment of a new Partnership Board. The nominations process for new Board members is now open. Nominations will close on 5 February 2016. The links below provide full details of the nominations process and the related forms for nominating candidates for the new Partnership Board.

[Board Nomination form]
[Board Nomination pack]

Since 1998, the Roll Back Malaria Partnership (RBM) – hosted by the World Health Organization (WHO) – has been central to the global fight against malaria. The past fifteen years have seen tremendous gains in reducing the burden of disease and progressing towards malaria elimination. According to the World Malaria Report 2015, released on 9 December 2015, more than half (57) of the 106 countries with malaria in 2000 had achieved reductions in new malaria cases of at least 75% by 2015. In that same time frame, 18 countries reduced their malaria cases by 50-75%.

The success of the RBM Partnership in harmonizing partner action against malaria has enabled us to set an even more ambitious target for the next 15 years: with the WHO Global Technical Strategy (GTS) and accompanying RBM Action and Investment to defeat Malaria (AIM) setting our collective sights on a further 90% reduction by 2030; and the Global Goals for Sustainable Development under Target 3.3 calling on partners to "end" malaria. The expected cost to achieve these goals is currently estimated at ~$100 Billion, setting us an equally ambitious resource mobilization challenge to meet these targets.

Every four to five years, RBM has commissioned an External Evaluation to ensure the Partnership remains fit-for-purpose to drive continued momentum towards a malaria-free world. The most recent evaluation in December 2013 highlighted that significant adjustments to RBM’s structure would be necessary to sustain its successes and build on them to deliver on the GTS’ ambitious 2030 goals and objectives. The External evaluation noted that the Partnership must be better able to support malaria-affected regions and countries with a high burden of disease, and adapt to overcome the significant barriers to realizing the targets in the GTS.

The report also noted that the changing malaria landscape and political environment would require the Partnership to be better equipped to advocate for financing at the highest levels in the increasingly complex world of international development and global health finance. The RBM partnership needs to marshal the international community and build the necessary national contributions and capacity to mobilize the necessary resources to achieve malaria elimination.

After a considerable period of consultation, and with the end of the hosting relationship with WHO, RBM is ready to take forward a new structure that takes advantage of the tremendous skill, energy and effectiveness of its many partners and will move it conclusively into a new era that aims to have a world free of malaria.

To make the revitalized Partnership fit-for-purpose, the RBM Board agreed at its 29th Meeting on a new governance architecture. This will include the establishment of a reconstituted Partnership Board to lead it, planned to be in place by March 2016. The nomination process for the new Partnership Board will be open from 9 January 2016 and 5 February 2016.

This Partnership Board will be selected to contain enhanced levels of skills and experience at a senior decision-making level as well as representation from across the Partnership, including malaria-affected countries, private sector, civil society, donor funding organisations, and entities outside the malaria and health sectors, civil society and donors.

Priorities for the new Partnership Board will include examination of alternatives for hosting for the RBM Partnership, recruiting a CEO, establishing the new partnership structures, and assessing and instituting new country and regional structures.

As we move into the new era of the RBM Partnership, we recognize how far we have already come in the fight against malaria, and the immense contributions of the Partnership and the outgoing RBM Secretariat. We are confident that the changes to the RBM Partnership architecture will result in a strengthened malaria partnership well-positioned to support the delivery of the ambitious goal of a malaria-free world.

14 December 2015, Chateau de Val Duchesse, Brussels : At a celebratory royal event to mark the progress in the fight against malaria, the RBM Executive Director Dr Fatoumata Nafo Traoré recognized the extraordinary commitment and tireless efforts of Princess Astrid during her 8 years as a Special Representative for the RBM Partnership. Speaking on behalf of hundreds of RBM Partners, Dr Nafo was joined by Ms. Barbara Pesce-Monteiro, the United Nations Secretary-General’s Representative at the EU who read a message from United Nations Secretary-General BAN Ki-moon; “Your unwavering commitment has helped save more than 6 million lives and achieve the malaria-related Millennium Development Goal. I applaud your remarkable compassion, resolute action and tireless activism. I am inspired by your personal commitment to humanity. “

Dr Traoré described H.R.H. Princess Astrid of Belgium as an inspiring and formidable force and signaled her undoubted contribution to the global malaria fight. “You have lent your voice to help some of the most marginalized communities around the globe. You have the heart of a true humanitarian, and you will forever be a part of the RBM family. Thank you for your devoted service,” said Dr Traoré. H.RH. Princess Astrid resigns from her role as Special Representative as the RBM Partnership undergoes restructuring to meet the needs of the new development era.

3rd December 2015 : During the Joint International Tropical Medicine Meeting in Bangkok, Thailand, representatives of WHO, RBM Secretariat, Asia Pacific Leaders Malaria Alliance and the Asia Pacific Malaria Elimination Network  debated the implications of Global Technical Strategy for Malaria and Roll Back Malaria Partnership’s Action and Investment to defeat Malaria AIM - 2016-2030 together with the region’s APLMA Elimination Roadmap.

Chaired by Prof. Jetsumon Prachumsri, Director of the Mahidol Vivax Research Center in Bangkok, key questions were raised about challenges such as migrant populations and drug and insecticide resistance, but the main discussion centered on concerns about harmonized policies, for severe malaria case management for example, and the possibility of having a single regulatory body to approve new antimalarial products for all Asia Pacific countries.

Sustained financing was also on the agenda as acceleration toward malaria elimination will require increased financing by the international donor community, as well as increased domestic financing by affected countries. 

The recent endorsement of the APLMA Malaria Elimination Roadmap by 18 leaders at the East Asian Summit (EAS) signifies the importance regional leaders assign to tackling the disease.  

http://www.malariaconsortium.org/events/29/joint-international-tropical-medicine-meeting-2015-jitmm-2015

Transition Support
A new Transition Support Team has been convened by Malaria No More UK in November 2015, to provide additional project management support to the Transition Oversight Committee. They will act as a central point of contact for the Transition over the coming months, providing Transition Management Support to the TOC and, if required, in transitioning to the incoming Board.

This small Transition Support Team is comprised of targeted programme and change management experts, led by Jonah Grunsell from Headadvisory Consulting based in the UK. They have extensive experience in leading transformational change programmes in the public and third sectors. Ian Boulton (TropMed Pharma Consulting) will also bring his insight and expertise from fifteen years of involvement with the fight against malaria and RBM to the team. They can be contacted at ProgTeam@RBMTransition.com.

The Restructuring Q&A has not been fully updated, but further information on the Restructuring Process is now available here.